TransMedics Group

Bewertungs-Analyse

Über das Unternehmen

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hea

Trading-Daten

Ähnliche Aktien aus dem Sektor

Wo kann ich TransMedics Group kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.